Jump to navigation
SRI Biosciences - Stanford Drug Discovery and Development Program to Explore New Molecular Target for Treatment of Triple Negative Breast Cancer - March 23, 2016
Balancing Widespread Use and Positive Learning Impacts of Educational Technology
Science and Engineering Indicators Give Policy Makers Better Information for Data-Based Decisions
SRI will be demonstrating its Sarnoff video testing tools at booth 211.
SRI immunologists will be presenting research findings on novel targets for treating autoimmune diseases and cancer.
SRI's Center for Vision Technologies will be demonstrating at its latest capabilities at booth 1511.
Press Release Archive
SRI's YouTube Channel
Material Usage Permissions